Your browser doesn't support javascript.
loading
A preoperative nomogram to predict the risk of synchronous distant metastases at diagnosis of primary breast cancer.
Boutros, C; Mazouni, C; Lerebours, F; Stevens, D; Lei, X; Gonzalez-Angulo, A M; Delaloge, S.
Afiliação
  • Boutros C; Department of Breast and Medical Oncology, Institut Gustave Roussy, Villejuif 94805, France.
  • Mazouni C; Department of Surgery, Division of Breast and Plastic Surgery, Institut Gustave Roussy, Villejuif 94805, France.
  • Lerebours F; Department of Breast and Medical Oncology, Institut Curie, Hôpital René Huguenin, Saint-Cloud, France.
  • Stevens D; Department of Breast and Medical Oncology, Institut Curie, Hôpital René Huguenin, Saint-Cloud, France.
  • Lei X; Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA.
  • Gonzalez-Angulo AM; Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • Delaloge S; Department of Breast and Medical Oncology, Institut Gustave Roussy, Villejuif 94805, France.
Br J Cancer ; 112(6): 992-7, 2015 Mar 17.
Article em En | MEDLINE | ID: mdl-25668007
ABSTRACT

BACKGROUND:

The detection of synchronous metastases at primary diagnosis of breast cancer (BC) affects its initial management. A risk calculator that incorporates many factors to evaluate an individual's risk of harbouring synchronous metastases would be useful to adapt cancer management. PATIENTS AND

METHODS:

Patients with primary diagnosis of BC were identified from three institutional databases sharing homogeneous work-up recommendations. A risk score for synchronous metastases was estimated and a nomogram was constructed using the first database. Its performance was assessed by receiver characteristic (ROC) analysis. The nomogram was externally validated in the two independent cohorts.

RESULTS:

A preoperative nomogram based on the clinical tumour size (P<0.001), clinical nodal status (P<0.001), oestrogen (P=0.17) and progesterone receptors (P=0.04) was developed. The nomogram accuracy was 87.3% (95% confidence interval (CI), 84.45-90.2%). Overall, the area under the ROC curve (AUC) was 86.1% for the validation set from the Institut Curie-René Huguenin, and 63.8% for the MD Anderson validation set. The negative predictive value (NPV) was high in the three cohorts (97-99%).

CONCLUSIONS:

We developed and validated a strong metastasis risk calculator that can evaluate with high accuracy an individual's risk of harbouring synchronous metastases at diagnosis of primary BC. CONDENSED ABSTRACT A nomogram to predict synchronous metastases at diagnosis of breast cancer was developed and externally validated. This tool allows avoiding unnecessary expensive work-up.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Nomogramas / Neoplasias Primárias Múltiplas Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Nomogramas / Neoplasias Primárias Múltiplas Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Br J Cancer Ano de publicação: 2015 Tipo de documento: Article País de afiliação: França